A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

PHASE3RecruitingINTERVENTIONAL

Enrollment

630

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions

Gastric Cancer

Interventions

DRUG

Docetaxel for injection (Albumin-bound)

Docetaxel for injection (Albumin-bound), by intravenous infusion, every 3 weeks

DRUG

Taxotere (docetaxel)

Taxotere, by intravenous infusion, every 3 weeks.

Trial Locations (1)

RECRUITING

CSPC Zhongqi Technology(SJZ) Ltd, Shijiazhuang

All Listed Sponsors

lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY